Recruiting
Phase 2

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Sponsor:

Stemedica Cell Technologies, Inc.

Code:

NCT02833792

Conditions

Alzheimer Dementia

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

Human Mesenchymal Stem Cells and Lactated Riunger's Solution

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Stemedica Cell Technologies, Inc. on 2022-10-28.